Hot cells and radiation shielding
Radioactive drugs are made and handled behind thick walls of lead, tungsten or concrete inside sealed, negative-pressure boxes with built-in robot arms, so the radiation stays contained and staff outside stay safe.
Overview
A hot cell is a sealed, negative-pressure, lead- or lead-and-steel-shielded enclosure, commonly fitted with leaded-glass viewing windows, mechanical manipulator arms or gloved arm-ports, HEPA/charcoal filtration and an integrated dose calibrator, used to contain the synthesis, dispensing and quality control of radiopharmaceuticals at activities that would otherwise give unacceptable doses to staff. Shielding thickness is calculated from the photon energy of the radionuclides handled and the required dose-reduction factor, expressed in half-value layers (HVL) or tenth-value layers (TVL): a few millimetres of lead attenuates the 140 keV gammas of Tc-99m, while the 511 keV annihilation photons from F-18 or other positron emitters need much thicker, dedicated high-density shielding (lead HVL around 4-5 mm at 511 keV, tenth-value layer around 15 mm), and Lu-177 and Ac-225 handling for therapeutic radiopharmacy needs shielding tailored to their specific gamma and bremsstrahlung emissions.
Source-side shielding (L-blocks, tungsten syringe and vial 'pig' shields, shielded transport containers) is generally more efficient than adding thickness to room walls, because it shields at the point of highest dose rate; tungsten's higher density (19.3 g/cm3 vs lead's 11.3 g/cm3) allows more compact shields where space near the operator is constrained, while lead remains the more economical choice for large, fixed room barriers. PET/F-18 radiopharmacies, I-131 therapy areas and Lu-177/Ac-225 handling suites each need shielding, ventilation and workflow (receipt, storage, dispensing, waste) sized to their specific radionuclide mix, and every hot cell installation is verified by a post-construction radiation survey against the physicist's calculated design goals before use.
How it works
Dense materials (lead, tungsten, concrete) placed between the radioactive source and people attenuate the emitted photons exponentially with thickness; the required thickness is calculated from the isotope's photon energy and the desired dose reduction, and is applied first at the source (syringe and vial shields, sealed hot-cell walls) because shielding close to a small source is far more efficient than shielding a whole room.
Dependencies
Open the dependency map →Dependencies are what this technology cannot be delivered without: manufacturing steps, instruments, software, upstream methods. See its full chain on the map.
Latest papers
topQuery for this technology: (TITLE:"Hot cells and radiation shielding" OR ABSTRACT:"Hot cells and radiation shielding" OR TITLE:"hot cell" OR ABSTRACT:"hot cell" OR TITLE:"L-block" OR ABSTRACT:"L-block" OR TITLE:"radiopharmacy shielding" OR ABSTRACT:"radiopharmacy shielding") AND (radiopharmaceutical OR radioligand OR radionuclide OR theranostic OR "nuclear medicine" OR "molecular imaging" OR radiotracer OR scintigraphy OR cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Hot cells and radiation shielding, not a curated reading list.
Similar pages
not linked directly; found by shared links- TechnologyRadiolabelling quality control
Shares Automated synthesis modules, Radiopharmaceutical GMP and releasing a drug that decays, Actinium-225, Lutetium-177 and the tag GMP.
- TermRadiopharmaceutical extravasation
Shares Gamma probes, handheld gamma cameras and dose calibrators, Radiopharmaceutical GMP and releasing a drug that decays, Technetium-99m, Fluorine-18.
- TermRadionuclidic purity
Shares Radiopharmaceutical GMP and releasing a drug that decays, Technetium-99m, Actinium-225, Fluorine-18.
- CollectionUS NRC 10 CFR Part 35 (Medical Use of Byproduct Material)
Shares Iodine-131, Actinium-225, Lutetium-177.
- BottleneckRadioactive waste handling and disposal regulation
Shares Radiopharmaceutical GMP and releasing a drug that decays, Lutetium-177 and the tag radiation safety.
- PersonNeeta Pandit-Taskar
Shares Iodine-131, Actinium-225, Fluorine-18.
- TermProduct release criteria (radiopharmaceutical quality control)
Shares Radiopharmaceutical GMP and releasing a drug that decays, Technetium-99m and the tag GMP.
- TechnologyRadiohybrid (rh) chemistry
Shares Actinium-225, Fluorine-18, Lutetium-177.